Inhaled Drug's heart effects scrutinized in small safety trial

NCT ID NCT00874237

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested whether a single inhaled dose of Staccato Loxapine affects the heart's electrical activity in 48 healthy adults. Participants received the drug, a placebo, and a control drug in random order, and their heart rhythms were measured. The goal was to check for heart-related side effects, not to treat any disease. The study found no major heart risks at the tested dose.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THOROUGH QT/QTC STUDY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Covance Clinical Research Unit Inc.

    Evansville, Indiana, 47710, United States